Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-24

Clinical Trial Update: Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing [NA]

View source ↗

Summary

A completed study evaluating resiliency training delivered to adults with neurofibromatosis via live videoconferencing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatoses, Neurofibromatosis 1 | NA | Status: COMPLETED